Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 222
Filtrar
1.
Transpl Infect Dis ; 22(5): e13382, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32583620

RESUMEN

BACKGROUND: The impact of COVID-19 on heart transplant (HTx) recipients remains unclear, particularly in the early post-transplant period. METHODS: We share novel insights from our experience in five HTx patients with COVID-19 (three within 2 months post-transplant) from our institution at the epicenter of the pandemic. RESULTS: All five exhibited moderate (requiring hospitalization, n = 3) or severe (requiring ICU and/or mechanical ventilation, n = 2) illness. Both cases with severe illness were transplanted approximately 6 weeks before presentation and acquired COVID-19 through community spread. All five patients were on immunosuppressive therapy with mycophenolate mofetil (MMF) and tacrolimus, and three that were transplanted within the prior 2 months were additionally on prednisone. The two cases with severe illness had profound lymphopenia with markedly elevated C-reactive protein, procalcitonin, and ferritin. All had bilateral ground-glass opacities on chest imaging. MMF was discontinued in all five, and both severe cases received convalescent plasma. All three recent transplants underwent routine endomyocardial biopsies, revealing mild (n = 1) or no acute cellular rejection (n = 2), and no visible viral particles on electron microscopy. Within 30 days of admission, the two cases with severe illness remain hospitalized but have clinically improved, while the other three have been discharged. CONCLUSIONS: COVID-19 appears to negatively impact outcomes early after heart transplantation.


Asunto(s)
Aloinjertos/patología , COVID-19/inmunología , Endocardio/patología , Rechazo de Injerto/patología , Trasplante de Corazón/efectos adversos , Miocardio/patología , Anciano , Aloinjertos/inmunología , Aloinjertos/ultraestructura , Biopsia , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/patología , Prueba de Ácido Nucleico para COVID-19 , Endocardio/inmunología , Endocardio/ultraestructura , Femenino , Rechazo de Injerto/inmunología , Rechazo de Injerto/prevención & control , Humanos , Inmunosupresores/efectos adversos , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Miocardio/inmunología , Miocardio/ultraestructura , Ciudad de Nueva York/epidemiología , Pandemias , Estudios Retrospectivos , SARS-CoV-2/inmunología , SARS-CoV-2/aislamiento & purificación , Índice de Severidad de la Enfermedad , Factores de Tiempo
2.
Cardiovasc Pathol ; 30: 64-71, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28779645

RESUMEN

Vacuolar degeneration of cardiomyocytes is a histological finding commonly encountered during routine light microscopic examination of human endomyocardial biopsy specimens. The vacuoles appear as intracellular clear areas lacking myofibers. By itself, this finding has little diagnostic value, but may have important clinical implications when the vacuolar contents are of etiological significance (e.g., accumulation of abnormal metabolites), and the clinical importance is increased when the disease is treatable. Thanks to its great resolving power, electron microscopy can often reveal the contents of the vacuoles and lead to a correct diagnosis. It can be used to differentially diagnose lysosomal storage diseases such as Fabry, Danon, and Pompe disease, doxorubicin cardiomyopathy, mitochondrial cardiomyopathy, autophagic degeneration, and accumulation of subcellular organelles (mitochondria, lipofuscin, glycogen granules, endoplasmic reticulum, etc.) as a nonspecific finding in failing cardiomyocytes. Nonetheless, undiagnosed cases certainly remain. It is strongly recommended that small pieces of tissue samples be fixed for electron microscopy at every endomyocardial biopsy procedure, and electron microscopic examination should be performed when a marked vacuolar degeneration is found.


Asunto(s)
Endocardio/ultraestructura , Miocardio/ultraestructura , Miocitos Cardíacos/ultraestructura , Autofagia , Biopsia , Cardiomiopatías/patología , Humanos , Enfermedades por Almacenamiento Lisosomal/patología , Microscopía Electrónica de Transmisión , Mitocondrias Cardíacas/ultraestructura , Vacuolas/ultraestructura
3.
Anat Rec (Hoboken) ; 299(8): 1080-9, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27178481

RESUMEN

Development of the endocardium in the heart of 4 to 4·1/2-day-incubated chick embryos was observed light and electron microscopically, and these results were evaluated by immunohistochemistry for desmin, FLK1 (VEGFR-2) or CD31, and by in situ hybridization assays for flk1-mRNA expression. At this developmental stage, the atrium and the ventricle were already discriminated by formation of the atrio-ventricular junction. The cardiac wall consisted of three layers; the inner endocardium, the middle myocardium, and the outer epicardium. The developing endocardium was seen as a chain of single-layered endocardial cells. Along its inner surface, numerous clusters of blood corpuscles were distributed, which seemed to contain some undifferentiated endocardial cells estimated from their characteristic ultrastructure and histological topography. Several blood corpuscles were in directly contact with the myocardium at the missing portions of the developing endocardial cell-chains. Differentiating endocardial cells individually showed roundish, small and large crescent, or flat in shapes. Such a prominent change of cell shapes appeared to be in parallel with their secretory activity during the transformation from the undifferentiated cells to the endocardial cells. Furthermore, immunohistochemistry for FLK1 or CD31, and in situ hybridization assays for flk1-mRNA labeled the cells composing developing endocardial cell-chains. Though these expressional analyses could not document clearly the transition of precursor cells into endocardial cells, the present study provided for the first time some important information regarding the morphological transition process toward endocardial cells at ultrastructural levels. Anat Rec, 299:1080-1089, 2016. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Endocardio/ultraestructura , Regulación del Desarrollo de la Expresión Génica , Corazón/anatomía & histología , Corazón/embriología , Microscopía Electrónica/métodos , Animales , Embrión de Pollo , Endocardio/embriología , Técnicas para Inmunoenzimas , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo
4.
J Mol Cell Cardiol ; 90: 139-45, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26686990

RESUMEN

The transcription factor Wilms' Tumor-1 (WT1) is essential for cardiac development. Deletion of Wt1 in mice results in disturbed epicardial and myocardial formation and lack of cardiac vasculature, causing embryonic lethality. Little is known about the role of WT1 in the human fetal heart. Therefore, as a first step, we analyzed the expression pattern of WT1 protein during human cardiac development from week 4 till week 20. WT1 expression was apparent in epicardial, endothelial and endocardial cells in a spatiotemporal manner. The expression of WT1 follows a pattern starting at the epicardium and extending towards the lumen of the heart, with differences in timing and expression levels between the atria and ventricles. The expression of WT1 in cardiac arterial endothelial cells reduces in time, whereas WT1 expression in the endothelial cells of cardiac veins and capillaries remains present at all stages studied. This study provides for the first time a detailed description of the expression of WT1 protein during human cardiac development, which indicates an important role for WT1 also in human cardiogenesis.


Asunto(s)
Células Endoteliales/metabolismo , Corazón Fetal/metabolismo , Regulación del Desarrollo de la Expresión Génica , Proteínas WT1/genética , Endocardio/crecimiento & desarrollo , Endocardio/metabolismo , Endocardio/ultraestructura , Células Endoteliales/ultraestructura , Endotelio Vascular/crecimiento & desarrollo , Endotelio Vascular/metabolismo , Endotelio Vascular/ultraestructura , Corazón Fetal/crecimiento & desarrollo , Corazón Fetal/ultraestructura , Feto , Humanos , Miocardio/metabolismo , Miocardio/ultraestructura , Pericardio/crecimiento & desarrollo , Pericardio/metabolismo , Pericardio/ultraestructura , Proteínas WT1/metabolismo
5.
Cardiovasc Pathol ; 24(6): 388-94, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26363814

RESUMEN

BACKGROUND: Endocardial fibroelastosis (EFE) is a pathologic condition of abnormal deposition of collagen and elastin within the endocardium of the heart. It is seen in conjunction with a variety of diseases including hypoplastic left heart syndrome and viral endocarditis. While an experimental model using heterotopic heart transplant in rats has been described, we sought to fully describe a mouse model that can be used to further elucidate the potential mechanisms of and treatments for EFE. MATERIALS AND METHODS: The hearts of 2-day-old C57BL/6 mice were transplanted into the abdomen of 7-week-old C57BL/6 mice. At 2 weeks, the hearts were harvested and histologic analysis was performed using hematoxylin and eosin, Masson's trichrome, Russell-Movat's pentachrome, Picrosirius red, Hart's, Verhoeff-Van Gieson, and Weigert's Resorcin-Fuchsin stains. Additionally, one heart was analyzed using transmission electron microscopy (TEM). RESULTS: Specimens demonstrated abnormal accumulation of both collagen and elastin within the endocardium with occasional expansion into the myocardium. Heterogeneity in extracellular matrix deposition was noted in the histologic specimens. In addition, TEM demonstrated the presence of excess collagen within the endocardium. CONCLUSIONS: The heterotopic transplantation of an immature heart into a mouse results in changes consistent with EFE. This model is appropriate to investigate the etiology and treatment of EFE.


Asunto(s)
Fibroelastosis Endocárdica/patología , Endocardio/patología , Trasplante de Corazón , Factores de Edad , Animales , Colágeno/metabolismo , Modelos Animales de Enfermedad , Elastina/metabolismo , Fibroelastosis Endocárdica/diagnóstico por imagen , Fibroelastosis Endocárdica/etiología , Fibroelastosis Endocárdica/metabolismo , Endocardio/diagnóstico por imagen , Endocardio/metabolismo , Endocardio/ultraestructura , Matriz Extracelular/metabolismo , Ratones Endogámicos C57BL , Factores de Tiempo , Ultrasonografía
6.
Circ Heart Fail ; 8(1): 149-55, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25466765

RESUMEN

BACKGROUND: Extravascular smooth muscle cells are often observed in the endocardium of human failing hearts. Here, we characterized the phenotype of those cells and investigated their physiological significance. METHODS AND RESULTS: We examined left ventricular biopsy specimens obtained from 44 patients with dilated cardiomyopathy and 6 nonfailing hearts. In Masson trichrome-stained histological preparations, bundles of smooth muscle cells were seen localized in the endocardium in 23 of the 44 specimens (none of the 6 controls). These cells were immunopositive for α-smooth muscle actin, type 2 smooth muscle myosin, desmin, and calponin, but were negative for embryonic smooth muscle myosin, vimentin, fibronectin, and periostin. This profile is indicative of a late differentiation (contractile) smooth muscle phenotype. Electron microscopy confirmed that phenotype, revealing the cells to contain abundant myofilaments with dense bodies but little rough endoplasmic reticulum or Golgi apparatus. In the endocardial smooth muscle-positive group, the left ventricular end-systolic volume index (73±34 versus 105±50 mL/m(2); P=0.021), left ventricular peak wall stress (164±47 versus 196±43 dynes 10(3)/cm(2); P=0.023), and left ventricular end-systolic meridional wall stress (97±38 versus 121±37 dynes 10(3)/cm(2); P=0.036) were all significantly smaller, and the ejection fraction was larger (41±8.8 versus 33±9.3%; P=0.005) than in the endocardial smooth muscle-negative group. However, no histological parameters differed between the 2 groups. CONCLUSIONS: Endocardial smooth muscle cell bundles in hearts with dilated cardiomyopathy exhibit a mature contractile phenotype and may play a compensatory role mitigating heart failure by reducing left ventricular wall stress and systolic dysfunction.


Asunto(s)
Endocardio/ultraestructura , Insuficiencia Cardíaca/fisiopatología , Contracción Miocárdica , Miocitos del Músculo Liso/fisiología , Función Ventricular Izquierda/fisiología , Adolescente , Adulto , Anciano , Biopsia , Angiografía Coronaria , Progresión de la Enfermedad , Ecocardiografía , Femenino , Estudios de Seguimiento , Insuficiencia Cardíaca/diagnóstico , Humanos , Inmunohistoquímica , Masculino , Microscopía Electrónica , Persona de Mediana Edad , Miocitos del Músculo Liso/ultraestructura , Fenotipo , Estudios Retrospectivos , Volumen Sistólico , Adulto Joven
7.
Mater Sci Eng C Mater Biol Appl ; 33(3): 1355-60, 2013 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-23827582

RESUMEN

Atrial septal defect (ASD) occlusion devices made of nickel-titanium (NiTi) have a major shortcoming in that they release nickel into the body. We modified NiTi occluders using Arc Ion Plating technology. Nano lamellar titanium-nitrogen (TiN) coatings were formed on the surfaces of the occluders. The safety and efficacy of the modified NiTi occluders were evaluated in animal model. The results showed that 38 out of 39 rams (97%) survived at the end of the experiment. Fibrous capsules formed on the surfaces of the devices. Gradual endothelialization took place through the attachment of endothelial progenitor cells from the blood and the migration of endothelial cells from adjacent endocardium. The neo-endocardium formed more quickly in the coated group than in the uncoated group, as indicated by the evaluation of the six month study group. After TiN coating, there was no significant difference in endothelial cell cycle. TiN coating significantly reduced the release of nickel in both in vivo and in vitro indicating an improved biocompatibility of the nitinol ASD occluders. Superior and modified ASD occluders may provide a good choice for people with nickel allergies after sFDA registration, which is expected in one to two years.


Asunto(s)
Aleaciones/efectos adversos , Materiales Biocompatibles Revestidos/efectos adversos , Defectos del Tabique Interatrial/terapia , Nanoestructuras/efectos adversos , Níquel/efectos adversos , Dispositivo Oclusor Septal , Titanio/efectos adversos , Animales , Ciclo Celular , Endocardio/metabolismo , Endocardio/patología , Endocardio/ultraestructura , Células Endoteliales/metabolismo , Células Endoteliales/patología , Defectos del Tabique Interatrial/sangre , Implantes Experimentales , Masculino , Nanoestructuras/ultraestructura , Níquel/sangre , Implantación de Prótesis , Ovinos , Resultado del Tratamiento
8.
Europace ; 15(11): 1557-61, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23608029

RESUMEN

AIMS: To examine morphology and mechanical properties of the atrial 'intima', which we defined as the tissue interposed between atrial endocardium and myocardium, in patients without known cardiovascular disease. METHODS AND RESULTS: Post-mortem right and left atrial tissue was obtained from male infants (<1 year, n = 4), children (10-19 years, n = 4), and adults (58-69 years, n = 7). Using light microscopy and an ocular micrometer, atrial intimal (AIT) thickness was measured. Intimal collagen bundle thickness was measured using electron microscopy. Passive atrial wall stiffness was measured using a planar biaxial testing device. Among infants, left AIT (0.2 ± 0.2 mm) and right (0.2 ± 0.1 mm) AIT were not significantly different (P = 0.84). Among children, left AIT (0.6 ± 0.2 mm) was significantly greater than right (0.2 ± 0.1 mm) AIT (P = 0.03), and left AIT was marginally greater than in infants (P = 0.07). Among adults, with the exception of the appendage region, left AIT (1.0 ± 0.2 mm) was markedly greater than right AIT (0.3 ± 0.1 mm; P < 0.05), and left AIT was significantly greater than that in other age groups (P < 0.05). There were no differences in right AIT among age groups. Left intimal collagen bundle thickness was greater in adults (0.0512 ± 0.0056 µm) than infants (0.0432 ± 0.0071 µm) or children (0.0435 ± 0.0013 µm), and bundles were less organized. Wall stiffness was attributable primarily to the intima (1245 ± 132, vs. 260 ± 45 N/m(2) for the remaining atrial wall). CONCLUSION: The left atrial intima, but not the right, thickens with age, becomes more disorganized ultrastructurally, and is responsible for the majority of atrial wall stiffness.


Asunto(s)
Endocardio/ultraestructura , Atrios Cardíacos/ultraestructura , Miocardio/ultraestructura , Adolescente , Factores de Edad , Anciano , Autopsia , Niño , Colágeno/ultraestructura , Endocardio/patología , Atrios Cardíacos/patología , Humanos , Lactante , Recién Nacido , Masculino , Microscopía , Microscopía Electrónica , Persona de Mediana Edad , Miocardio/patología , Adulto Joven
9.
Circ Arrhythm Electrophysiol ; 6(2): 279-86, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23476031

RESUMEN

BACKGROUND: Silicone catheter insulation, larynx prostheses undergo biodegradation. The aims of the study were to verify the conviction that outer silicone lead insulation is biostable and inert in addition to determining the role of macrophages (M) and Staphylococcus aureus (S aureus) strains in the silicone lead insulation degradation. METHODS AND RESULTS: Leads removed from 8 patients because of infective and noninfective indications were analyzed with stereomicroscope and classified according to Banacha abrasion classification, and additional analysis using scanning electron microscope was performed. The examination revealed excavations of different shape and depth in the abraded areas. Fresh silicone-insulated lead was cut into fragments. The fragments were cultured with RAW 264.7 macrophage cell line for 9 weeks. Additional lead fragments were placed with S aureus strains: ATCC 25923, ATCC 29213, and K9328H. Lead fragments were also cocultured with the bacterial strains and RAW M. In scanning electron microscope analysis, diminution in silicone was observed. All S aureus strains provoked insulation damage after 9 weeks. The lowest level of degradation of insulation concerned ATCC 25923. Silicone lead fragments in cocultures presented a further gone level of silicone biodegradation. CONCLUSIONS: S aureus, macrophages separately, and S aureus and macrophages cocultures initiate the biodegradation of silicone insulation. Differences in the level of biodegradation between strains of S aureus were observed, with the most aggressive reaction toward silicone visible in the cocultures. In vivo silicone biodegradation is initiated by tearing among surfaces of the lead insulation, macrophages may be the crucial cells for the process that may be aggravated by pathogen colonization.


Asunto(s)
Implantes Absorbibles/microbiología , Endocardio/microbiología , Marcapaso Artificial/microbiología , Infecciones Relacionadas con Prótesis/microbiología , Elastómeros de Silicona , Infecciones Estafilocócicas/microbiología , Staphylococcus aureus/aislamiento & purificación , Adolescente , Anciano , Anciano de 80 o más Años , Endocarditis Bacteriana/etiología , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/patología , Endocardio/ultraestructura , Femenino , Humanos , Macrófagos/patología , Masculino , Microscopía Electrónica de Rastreo , Persona de Mediana Edad , Marcapaso Artificial/efectos adversos , Infecciones Relacionadas con Prótesis/patología , Infecciones Estafilocócicas/patología
10.
Nat Commun ; 4: 1564, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23463007

RESUMEN

Haematopoietic cells arise from spatiotemporally restricted domains in the developing embryo. Although studies of non-mammalian animal and in vitro embryonic stem cell models suggest a close relationship among cardiac, endocardial and haematopoietic lineages, it remains unknown whether the mammalian heart tube serves as a haemogenic organ akin to the dorsal aorta. Here we examine the haemogenic activity of the developing endocardium. Mouse heart explants generate myeloid and erythroid colonies in the absence of circulation. Haemogenic activity arises from a subset of endocardial cells in the outflow cushion and atria earlier than in the aorta-gonad-mesonephros region, and is transient and definitive in nature. Interestingly, key cardiac transcription factors, Nkx2-5 and Isl1, are expressed in and required for the haemogenic population of the endocardium. Together, these data suggest that a subset of endocardial/endothelial cells serve as a de novo source for transient definitive haematopoietic progenitors.


Asunto(s)
Endocardio/fisiología , Hematopoyesis/fisiología , Animales , Endocardio/citología , Endocardio/embriología , Endocardio/ultraestructura , Células Endoteliales/citología , Células Endoteliales/metabolismo , Células Endoteliales/ultraestructura , Células Eritroides/citología , Técnica del Anticuerpo Fluorescente , Atrios Cardíacos/citología , Atrios Cardíacos/ultraestructura , Sistema Hematopoyético/citología , Sistema Hematopoyético/fisiología , Proteína Homeótica Nkx-2.5 , Proteínas de Homeodominio/metabolismo , Proteínas con Homeodominio LIM/metabolismo , Hígado/metabolismo , Ratones , Células Mieloides/citología , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/metabolismo , Glicoproteína IIb de Membrana Plaquetaria/metabolismo , Factores de Transcripción/metabolismo
11.
Cardiology ; 118(1): 1-7, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21372571

RESUMEN

BACKGROUND: Although there have been reports on threadlike structures inside the heart, they have received little attention. We aimed to develop a method for observing such structures and to reveal their ultrastructures. METHODS: An in situ staining method, which uses a series of procedures of 0.2-0.4% trypan blue spraying and washing, was applied to observe threadlike structures on the surfaces of endocardia. The threadlike structures were isolated and observed by using confocal laser scanning microscopy (CLSM) and transmission electron microscopy (TEM). RESULTS: Networks of endocardial vessels (20 µm in thickness) with expansions (40-100 µm in diameter) were visualized; they were movable on the endocardium of the bovine atrium and ventricle. CLSM showed that (1) rod-shaped nuclei were aligned along the longitudinal direction of the endocardial vessel and (2) there were many cells inside the expansion. TEM on the endocardial vessel revealed that (1) there existed multiple lumens (1-7 µm in diameter) and (2) the extracellular matrices mostly consisted of collagen fibers, which were aligned along the longitudinal direction of the endocardial vessel or were locally organized in reticular structures. CONCLUSION: We investigated the endocardial circulatory system in bovine cardiac chambers and its ultrastructures, such as nucleic distributions, microlumens, and collagenous extracellular matrices.


Asunto(s)
Vasos Coronarios/ultraestructura , Endocardio/ultraestructura , Animales , Bovinos , Colorantes , Azul de Tripano
12.
J Cell Mol Med ; 15(12): 2594-600, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21435170

RESUMEN

Blood vessels are highly organized and complex structure, which are far more than simple tubes conducting the blood to almost any tissue of the body. The fine structure of the wall of blood vessels has been studied previously using the electron microscope, but the presence the telocytes associated with vasculature, a specific new cellular entity, has not been studied in depth. Interestingly, telocytes have been recently found in the epicardium, myocardium, endocardium, human term placenta, duodenal lamina propria and pleura. We show the presence of telocytes located on the extracellular matrix of blood vessels (arterioles, venules and capillaries) by immunohistochemistry and transmission electron microscopy. Also, we demonstrated the first evidence of a primary cilium in telocytes. Several functions have been proposed for these cells. Here, the telocyte-blood vessels cell proximity, the relationship between telocytes, exosomes and nervous trunks may have a special significance.


Asunto(s)
Arteriolas/ultraestructura , Capilares/ultraestructura , Células Intersticiales de Cajal/ultraestructura , Vénulas/ultraestructura , Animales , Arteriolas/citología , Capilares/citología , Células Cultivadas , Endocardio/citología , Endocardio/ultraestructura , Humanos , Células Intersticiales de Cajal/citología , Microscopía Electrónica de Transmisión , Miocardio/citología , Miocardio/ultraestructura , Pericardio/citología , Pericardio/ultraestructura , Pleura/citología , Pleura/ultraestructura , Ratas , Ratas Wistar , Vénulas/citología
13.
J Cell Mol Med ; 14(9): 2330-4, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20716125

RESUMEN

The term TELOCYTES was very recently introduced, for replacing the name Interstitial Cajal-Like Cells (ICLC). In fact, telocytes are not really Cajal-like cells, they being different from all other interstitial cells by the presence of telopodes, which are cell-body prolongations, very thin (under the resolving power of light microscopy), extremely long (tens up to hundreds of micrometers), with a moniliform aspect (many dilations along), and having caveolae. The presence of telocytes in epicardium and myocardium was previously documented. We present here electron microscope images showing the existence of telocytes, with telopodes, at the level of mouse endocardium. Telocytes are located in the subendothelial layer of endocardium, and their telopodes are interposed in between the endocardial endothelium and the cardiomyocytes bundles. Some telopodes penetrate from the endocardium among the cardiomyocytes and surround them, eventually. Telopodes frequently establish close spatial relationships with myocardial blood capillaries and nerve endings. Because we may consider endocardium as a 'blood-heart barrier', or more exactly as a 'blood-myocardium barrier', telocytes might have an important role in such a barrier being the dominant cell population in subendothelial layer of endocardium.


Asunto(s)
Endocardio/citología , Endocardio/ultraestructura , Células Intersticiales de Cajal/citología , Células Intersticiales de Cajal/ultraestructura , Microscopía Electrónica , Animales , Atrios Cardíacos/citología , Atrios Cardíacos/ultraestructura , Ventrículos Cardíacos/citología , Ventrículos Cardíacos/ultraestructura , Ratones
14.
Cardiol Young ; 20(2): 115-23, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20346203

RESUMEN

Endocardial fibroelastosis is not a disease but a reaction of the endocardium. I review the history of the term with emphasis on the gradual understanding of the many causes of this reaction. I include a comprehensive list of diseases or other cardiac stresses that authors have reported in association, and I try to explain the mechanism of the reaction. Although endocardial fibroelastosis is rare today, I issue a warning of a possible epidemic recrudescence of some of the associated diseases. My hope is for nosologic purity, therefore that outworn but surviving concepts will be firmly rejected.


Asunto(s)
Fibroelastosis Endocárdica/patología , Fibroelastosis Endocárdica/fisiopatología , Cardiomiopatías/clasificación , Fibroelastosis Endocárdica/diagnóstico por imagen , Fibroelastosis Endocárdica/embriología , Fibroelastosis Endocárdica/epidemiología , Endocardio/ultraestructura , Enfermedades Fetales/diagnóstico por imagen , Humanos , No Compactación Aislada del Miocardio Ventricular/patología , Contracción Miocárdica/fisiología , Miocardio/patología , Terminología como Asunto , Ultrasonografía Prenatal
15.
Circulation ; 119(19): 2561-7, 2009 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-19414635

RESUMEN

BACKGROUND: In classic Fabry patients, accelerated coronary atherosclerosis and left ventricular hypertrophy manifest in the fourth decade; however, signs of cardiovascular disease also are observed later in life in "cardiac variant" patients and symptomatic female heterozygotes. These disturbances are caused by globotriaosylceramide (GL-3) accumulation in the heart resulting from lysosomal alpha-galactosidase A deficiency. METHODS AND RESULTS: We analyzed pretreatment and posttreatment endomyocardial biopsies from 58 Fabry patients enrolled in a 5-month, phase 3, double-blind, randomized, placebo-controlled trial, followed by a 54-month open-label extension study of recombinant human alpha-galactosidase A. Baseline evaluations revealed GL-3 deposits in interstitial capillary endothelial cells and large, laminated inclusions within cardiomyocytes. In this study, we evaluated microvascular GL-3 clearance; no clearance of GL-3 was observed in the cardiomyocytes during this trial. Five months of recombinant human alpha-galactosidase A treatment in the phase 3 trial resulted in complete microvascular clearance of GL-3 from 72% of treated patients compared with only 3% of placebo patients (P<0.001). The placebo group achieved similar results after 6 months of treatment in the open-label trial. In addition, the capillary endothelium remained free of GL-3 for up to 60 months in 6 of 8 patients who consented to an end-of-study biopsy. CONCLUSIONS: The findings suggest that long-term treatment with recombinant human alpha-galactosidase A may halt the progression of vascular pathology and prevent the clinical manifestations of atherosclerotic disease. This histopathological study should be a useful guide for clinicians and pathologists who diagnose and follow Fabry patients.


Asunto(s)
Biopsia , Enfermedad Coronaria/tratamiento farmacológico , Endocardio/patología , Enfermedad de Fabry/complicaciones , Trihexosilceramidas/metabolismo , alfa-Galactosidasa/uso terapéutico , Adolescente , Adulto , Capilares/química , Capilares/patología , Ensayos Clínicos Fase III como Asunto , Enfermedad de la Arteria Coronaria/prevención & control , Enfermedad Coronaria/etiología , Enfermedad Coronaria/patología , Enfermedad Coronaria/prevención & control , Método Doble Ciego , Endocardio/ultraestructura , Endotelio Vascular/química , Endotelio Vascular/patología , Femenino , Humanos , Cuerpos de Inclusión/química , Cuerpos de Inclusión/ultraestructura , Lisosomas/enzimología , Masculino , Microcirculación , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/patología , Ensayos Clínicos Controlados Aleatorios como Asunto , Proteínas Recombinantes/uso terapéutico , Trihexosilceramidas/análisis , Adulto Joven
16.
Int J Cardiol ; 136(1): 99-102, 2009 Jul 24.
Artículo en Inglés | MEDLINE | ID: mdl-18606469

RESUMEN

Acute starvation effects for connexin-43 protein expression, in the heart, had not been previously explored. Hence we examined acute fasting on the myocardial immuno-histochemical expression of connexin-43 in 3 groups of 8-week old female BALB/c mice. Groups consisted of control mice (n=5), fasting for 24 h (N=5) and 48 h (N=3). Under light microscopy all control fed cases revealed the presence of some immuno-detectable staining for connexin-43 that is either present or weakly observed in some or all of the regions of interest, that include the cross-sectional left ventricular sub-endocardium, mid-myocardium and papillary muscle. Whereas mice that underwent 24 or 48 h of acute starvation, connexin-43 expression was either difficult to detect visually (N=3) or was completely absent (N=5) at 40x magnification using a light microscope. In starved mice with no membrane staining for connexin-43 we observed an increase in the intracellular accumulation of cytoplasmic connexin-43 expression.


Asunto(s)
Conexina 43/antagonistas & inhibidores , Regulación hacia Abajo/fisiología , Ayuno/fisiología , Miocitos Cardíacos/química , Animales , Conexina 43/biosíntesis , Conexina 43/ultraestructura , Endocardio/química , Endocardio/ultraestructura , Femenino , Ventrículos Cardíacos/química , Ventrículos Cardíacos/ultraestructura , Inmunohistoquímica , Ratones , Ratones Endogámicos BALB C , Miocitos Cardíacos/ultraestructura , Músculos Papilares/química , Músculos Papilares/ultraestructura , Transporte de Proteínas/fisiología , Factores de Tiempo
17.
Fiziol Zh (1994) ; 54(5): 75-80, 2008.
Artículo en Ucraniano | MEDLINE | ID: mdl-19058516

RESUMEN

In experiments with white rats the influence of emotional and pain stress in combination with alimentary hypercholesterolemia on lipid content of membraneous structures of endotheliocytes of endocardium and microvessels of myocardium and their morphological manifestations has been studied. Combination of these etiological factors is followed by accumulation of free cholesterol and free fatty acids within the cells. This results in damage of single endotheliocytes, the most extreme manifestation of which is formation of endothelial bodies (cytoplasts) with development of microclasmatosis and desquamation of these cells.


Asunto(s)
Vasos Coronarios , Endocardio , Endotelio Vascular , Hipercolesterolemia , Metabolismo de los Lípidos , Estrés Psicológico , Animales , Cromatografía en Capa Delgada , Vasos Coronarios/metabolismo , Vasos Coronarios/ultraestructura , Modelos Animales de Enfermedad , Endocardio/metabolismo , Endocardio/ultraestructura , Células Endoteliales/metabolismo , Células Endoteliales/ultraestructura , Endotelio Vascular/metabolismo , Endotelio Vascular/ultraestructura , Hipercolesterolemia/complicaciones , Hipercolesterolemia/metabolismo , Hipercolesterolemia/patología , Lípidos/sangre , Masculino , Microscopía Electrónica , Miocardio/metabolismo , Miocardio/ultraestructura , Ratas , Estrés Psicológico/complicaciones , Estrés Psicológico/metabolismo , Estrés Psicológico/patología
18.
Am J Physiol Heart Circ Physiol ; 295(3): H1243-H1252, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18641274

RESUMEN

There is strong support for the view that the ventricular myocardium has a laminar organization in which myocytes are grouped into branching layers separated by cleavage planes. However, understanding of the extent and functional implications of this architecture has been limited by the lack of a systematic three-dimensional description of the organization of myocytes and associated perimysial collagen. We imaged myocytes and collagen across the left ventricular wall at high resolution in seven normal rat hearts using extended volume confocal microscopy. We developed novel reconstruction and segmentation techniques necessary for the quantitative analysis of three-dimensional myocyte and perimysial collagen organization. The results confirm that perimysial collagen has an ordered arrangement and that it defines a laminar organization. Perimysial collagen is composed of three distinct forms: extensive meshwork on laminar surfaces, convoluted fibers connecting adjacent layers, and longitudinal cords. While myolaminae are the principal form of structural organization throughout most of the wall, they are not seen in the subepicardium, where perimysial collagen is present only as longitudinal cords.


Asunto(s)
Colágeno/metabolismo , Colágeno/ultraestructura , Miocardio/metabolismo , Miocardio/ultraestructura , Animales , Endocardio/metabolismo , Endocardio/ultraestructura , Ventrículos Cardíacos/metabolismo , Ventrículos Cardíacos/ultraestructura , Procesamiento de Imagen Asistido por Computador , Masculino , Microscopía Confocal , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/ultraestructura , Pericardio/metabolismo , Pericardio/ultraestructura , Ratas , Ratas Endogámicas WKY , Ratas Wistar
19.
Toxicol Sci ; 100(2): 486-94, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17823451

RESUMEN

Aristolochic Acid (AA) is a component of Chinese herbs that has been found to be toxic to multiple organs in adults. Its toxicity to developing embryos has not been reported. Here, we describe that AA specifically causes heart defects in developing zebrafish embryos in a dosage-dependent manner. The treated embryos are able to develop their hearts normally up to 24 h postfertilization, when cardiac contraction initiates, but begin to show deformation and reduction of the hearts followed by gradual contractility loss and eventually lethality, suggesting that AA is primarily affecting cardiac physiology rather than cardiogenesis. Histological analyses reveal that the AA-treated hearts develop hypertrophy and disorganization of cardiomyocytes and loss of endocardium. By transmission electron microscopy, we observed broken and disorganized cardiac fibers in the AA-treated hearts. AA induces the expression of proinflammation genes, including cox-2, IL-1beta, and others. The AA-induced cardiac defects can be attenuated by the cox-2 antagonist NS398 via reducing the expression of the inflammatory genes. This attenuation could be further enhanced by known heart failure drugs, such as angiotensin-converting enzyme inhibitor and beta-adrenergic receptor antagonist. In contrast, the heart defects are enhanced by a beta-adrenergic receptor agonist. In summary, AA causes profound toxicity to zebrafish embryos that exhibit pathophysiological and pharmacological features resembling those of heart failure in humans and other model organisms, and thus, zebrafish could be a new model for studies on heart failure.


Asunto(s)
Ácidos Aristolóquicos/toxicidad , Embrión no Mamífero/efectos de los fármacos , Insuficiencia Cardíaca/inducido químicamente , Corazón/efectos de los fármacos , Inflamación/metabolismo , Mutágenos/toxicidad , Inhibidores de la Enzima Convertidora de Angiotensina/farmacología , Animales , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Inhibidores de la Ciclooxigenasa/farmacología , Relación Dosis-Respuesta a Droga , Doxorrubicina/toxicidad , Sinergismo Farmacológico , Embrión no Mamífero/fisiopatología , Endocardio/efectos de los fármacos , Endocardio/embriología , Endocardio/ultraestructura , Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Corazón/embriología , Insuficiencia Cardíaca/embriología , Insuficiencia Cardíaca/metabolismo , Inflamación/genética , Isoproterenol/farmacología , Metoprolol/farmacología , Contracción Miocárdica/efectos de los fármacos , Miocardio/metabolismo , Miocardio/ultraestructura , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/ultraestructura , Nitrobencenos/farmacología , Sulfonamidas/farmacología , Pez Cebra
20.
Basic Clin Pharmacol Toxicol ; 100(4): 233-9, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17371527

RESUMEN

In the present study, we investigated the cardioprotective effects of thalidomide in a rat model of acute myocardial injury, induced by subcutaneous injection of isoprenaline hemisulphate (85 mg/kg per day for 2 days). Thalidomide (75/150/300 mg/kg) or vehicle (dimethylsulphoxide) or saline (0.9% NaCl) was administered orally for 14 days and isoprenaline injection on the 12th and 13th days. Cardiovascular responses (arterial and left ventricular haemodynamic parameters and heart rate) were obtained in anaesthetized rats on the 14th day. Histopathological and electronmicroscopical analysis of myocardial injury was done. The results showed that thalidomide 300 mg/kg per day orally caused significant improvement in isoprenaline-induced reduction of cardiac function with increases in maximum rate of pressure development (+LVdP/dt, P < 0.001) and maximum rate of pressure decline (-LVdP/dt, P < 0.001) and decreases in left ventricular end-diastolic pressure (P < 0.01), systolic arterial pressure (P < 0.001), diastolic arterial pressure (P < 0.001), mean arterial pressure (P < 0.001) and heart rate (P < 0.001). The myocardial injury caused by isoprenaline was significantly reduced by thalidomide treatment as judged by the reduction of myocardial necrosis, ultrastructural changes such as mitochondria and myofibril damage, 300 mg/kg being the most effective dose. In conclusion, oral administration of thalidomide is able to ameliorate isoprenaline-induced myocardial injury and impaired myocardial function in spite of decreases in systolic arterial pressure, diastolic arterial pressure and mean arterial pressure, which may be due to its depressant effect on the sino-atrial node and sedative action.


Asunto(s)
Lesiones Cardíacas/prevención & control , Isoproterenol/toxicidad , Talidomida/farmacología , Administración Oral , Animales , Presión Sanguínea/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Endocardio/efectos de los fármacos , Endocardio/patología , Endocardio/ultraestructura , Corazón/efectos de los fármacos , Corazón/fisiopatología , Lesiones Cardíacas/inducido químicamente , Lesiones Cardíacas/patología , Frecuencia Cardíaca/efectos de los fármacos , Inmunosupresores/administración & dosificación , Inmunosupresores/farmacología , Inyecciones Subcutáneas , Isoproterenol/administración & dosificación , Masculino , Microscopía Electrónica de Transmisión , Mitocondrias Cardíacas/efectos de los fármacos , Mitocondrias Cardíacas/patología , Mitocondrias Cardíacas/ultraestructura , Miocardio/patología , Miocardio/ultraestructura , Miofibrillas/efectos de los fármacos , Miofibrillas/patología , Miofibrillas/ultraestructura , Ratas , Ratas Wistar , Talidomida/administración & dosificación , Función Ventricular Izquierda/efectos de los fármacos , Presión Ventricular/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...